Embed

Academic

Authors

A. Bernhardt

A. Bernhardt,Heinrich Heine University Düsseldorf,Oncology,Cell Biology,Physiology

Edit

A. Bernhardt

Heinrich Heine University Düsseldorf

Publications: 5 | Citations: 96

Fields: Oncology, Cell Biology, Physiology

Collaborated with 25 co-authors from 2003 to 2010 | Cited by 409 authors

Cumulative Annual

Sort by:

Publications (5)

BibTeX | RIS | RefWorks Download

Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patients (Citations: 3)

, , , , , , , ,

Journal: Annals of Oncology - ANN ONCOL , vol. 21, no. 7, 2010

P-29 RA and RARS with thrombocytosis:Mixed myelodysplastic/myeloproliferative disorder?

, , , , , , ,

Journal: Leukemia Research - LEUK RES , vol. 29, pp. S35-S35, 2005

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid (Citations: 82)

, , , , , , ,

Published in 2004.

Transplantation of allogeneic CD34 + -selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia (Citations: 4)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=32953467&selfId1=55765116&selfId2=0&maxNumber=12&query=

Journal: Cytotherapy , vol. 6, no. 6, pp. 533-542, 2004

Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma (Citations: 7)

, , , , ,

Journal: Bone Marrow Transplantation - BONE MARROW TRANSPLANT , vol. 32, no. 6, pp. 629-631, 2003

Sort by:

Citations (96 times by 96 publications)

Myelodysplastic Syndromes (Citations: 9)

, ,

Journal: Clinics in Laboratory Medicine - CLIN LAB MED , vol. 28, no. 4, pp. 258-272, 2011

Reduced Expression of Reelin ( RELN ) Gene Is Associated With High Recurrence Rate of Hepatocellular Carcinoma (Citations: 1)

, , , , , , , ,

Journal: Annals of Surgical Oncology - ANNALS SURG ONCOLOGY , vol. 18, no. 2, pp. 572-579, 2011

Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial (Citations: 2)

, , , , , , , , , , ,

Journal: Annals of Hematology - ANN HEMATOL , vol. 90, no. 4, pp. 379-387, 2011

Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia

, , , , , ,

Published in 2011.

Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia

, ,

Journal: Leukemia , vol. 25, no. 2, pp. 226-235, 2011

Comments

Co-authors (25)

Journals (4)

Keywords (15)

A. Bernhardt,Heinrich Heine University Düsseldorf,Oncology,Cell Biology,Physiology

Publications (5)

BibTeX | RIS | RefWorks Download

Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patients (Citations: 3)

P-29 RA and RARS with thrombocytosis:Mixed myelodysplastic/myeloproliferative disorder?

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid (Citations: 82)

Transplantation of allogeneic CD34 + -selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia (Citations: 4)

Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma (Citations: 7)

Citations (96 times by 96 publications)

Myelodysplastic Syndromes (Citations: 9)

Reduced Expression of Reelin ( RELN ) Gene Is Associated With High Recurrence Rate of Hepatocellular Carcinoma (Citations: 1)

Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial (Citations: 2)

Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia

Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia


	View FAQ about top research areas and Fields of study

Co-authors (25)

Journals (4)

Keywords (15)

A. Bernhardt,Heinrich Heine University Düsseldorf,Oncology,Cell Biology,Physiology

Publications (5) BibTeX | RIS | RefWorks Download

Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patients (Citations: 3)

P-29 RA and RARS with thrombocytosis:Mixed myelodysplastic/myeloproliferative disorder?

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid (Citations: 82)

Transplantation of allogeneic CD34 + -selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia (Citations: 4)

Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma (Citations: 7)

Citations (96 times by 96 publications)

Myelodysplastic Syndromes (Citations: 9)

Reduced Expression of Reelin ( RELN ) Gene Is Associated With High Recurrence Rate of Hepatocellular Carcinoma (Citations: 1)

Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial (Citations: 2)

Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia

Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia

Publications (5)

BibTeX | RIS | RefWorks Download